Healthbook WCLC Newsroom: Summery of IMpower133
Five year survival in patients with ES-SCLC treated with atezolizumab in IMpower133:
IMbrella A extension study results, presented by Prof. Rafal Dziadziuszko
Published: 31/01/24
Five year survival in patients with ES-SCLC treated with atezolizumab in IMpower133:
IMbrella A extension study results, presented by Prof. Rafal Dziadziuszko
Published: 31/01/24